LawPlayer
My bookmarksSign up freeSign up free
Source

2011/761/EU: Commission Implementing Decision of 24 November 2011 authorising the placing on the market of flavonoids from Glycyrrhiza glabra L. as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2011) 8362)

2011/761/EU: Commission Implementing Decision of 24 November 2011 authorising the placing on the market of flavonoids from Glycyrrhiza glabra L. as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2011) 8362)

Regulation (EC) No 258/97 · Decision · 5 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

Flavonoids from Glycyrrhiza glabra L. (hereinafter referred to as ‘Glavonoid’), as specified in Annex I, may be placed on the market in the Union as a novel food ingredient for the uses specified in Annex II. Glavonoid shall not be sold to the final consumer as such.

Article 2

Open ↗

1.   The designation of flavonoids from Glycyrrhiza glabra L. authorised by this Decision on the labelling of the foodstuffs containing it shall be ‘flavonoids from Glycyrrhiza glabra L.’. 2.   There shall be a statement on the labelling of the foods where the product was added as a novel food ingredient indicating that: (a) the product should not be consumed by pregnant and breast feeding women, children and young adolescents; and (b) people taking prescription drugs should only consume the product under medical supervision; (c) a maximum of 120 mg of Glavonoid per day should be consumed. 3.   The amount of Glavonoid in the final food shall be indicated on the labelling of the food containing it. 4.   Beverages containing Glavonoid shall be presented to the final consumer as single portions.

Article 3

Open ↗

This Decision is addressed to Kaneka Pharma Europe NV, Triomflaan 173, 1160 Brussels, Belgium.

Supplementary provisions

ANNEX ISupplementary provisions

Open ↗

ANNEX I SPECIFICATIONS OF GLAVONOID Description Glavonoid is an extract derived from the roots or rootstock of Glycyrrhiza glabra L. by extraction with ethanol followed by further extraction of this ethanolic extract with medium-chain triglycerides. It is a dark-brown coloured liquid, containing 2,5 % to 3,5 % of glabridin. Specifications Parameter   Moisture less than 0,5 % Ash less than 0,1 % Peroxide value less than 0,5 meq/kg Glabridin 2,5 to 3,5 % of fat Glycyrrhizinic acid less than 0,005 % Fat including polyphenol-type substances not less than 99 % Protein less than 0,1 % Carbohydrates not detectable

ANNEX IISupplementary provisions

Open ↗

ANNEX II Food category Maximum content of Glavonoid Beverages based on milk Beverages based on yoghurt Beverages based on fruits or vegetables 120 mg per daily portion Food supplements 120 mg per portion of daily consumption

Other acts of the same type
Commission Implementing Decision (EU) 2025/1529 of 29 July 2025 laying down rules for the application of Directive (EU) 2016/797 of the European Parliament and of the Council as regards a request from Finland not to apply the requirement to use the latest ETCS Baseline in the trackside installation set out in Commission Implementing Regulation (EU) 2023/1695 (notified under document C(2025) 5123)Council Decision (CFSP) 2025/1575 of 29 July 2025 amending Decision (CFSP) 2022/2319 concerning restrictive measures in view of the situation in HaitiCommission Implementing Decision (EU) 2025/1582 of 29 July 2025 concerning certain emergency measures relating to infection with lumpy skin disease virus in Italy and repealing Implementing Decision (EU) 2025/1318 (notified under document C(2025) 5362)Council Implementing Decision (EU) 2025/1705 of 29 July 2025 implementing Decision (CFSP) 2015/1333 concerning restrictive measures in view of the situation in LibyaCommission Implementing Decision (EU) 2025/1708 of 29 July 2025 concerning certain emergency measures relating to infection with lumpy skin disease virus in France and repealing Implementing Decision (EU) 2025/1336 (notified under document C(2025) 5363)Commission Implementing Decision (EU, Euratom) 2025/1709 of 29 July 2025 amending Implementing Decision (EU) 2023/1602 as regards to non-competitive auction allocationsCommission Decision (EU) 2025/1896 of 29 July 2025 on establishing the group of experts serving as the Network for the Prevention of Child Sexual AbuseCommission Decision (EU) 2025/2433 of 29 July 2025 on the aid scheme SA.51501 (2021/C) (ex 2019/NN) (ex (2018/N) implemented by Czechia in favour of large enterprises active in primary agricultural production (notified under document C(2025) 5149)Commission Decision of 28 July 2025 instructing the Central Administrator of the Union Registry to enter corrections to the national allocation tables of Czechia, Germany, France, the Netherlands and Finland into the Union RegistryCommission Decision of 28 July 2025 instructing the central administrator of the Union Registry to enter changes to the national allocation tables of Lithuania and Sweden into the Union RegistryCommission Decision of 25 July 2025 amending Decision 2011/C 253/04 of 29 August 2011 setting up a Payment Systems Market Expert Group as regards its period of validityCommission Implementing Decision (EU) 2025/1507 of 25 July 2025 rejecting an application for protection of a geographical indication in accordance with Article 52(1) of Regulation (EU) No 1151/2012 of the European Parliament and of the Council Erzurum Su Böreği (PGI) (notified under document C(2025) 4762)

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next